Evidence map›Paper›PMID 29614061›Full record

ArticleMolecules (Basel, Switzerland)2018

Synthesis, Structural Studies and Biological Evaluation of Connections of Thiosemicarbazide, 1,2,4-Triazole and 1,3,4-Thiadiazole with Palmitic Acid.

Michał Jóźwiak, Karolina Stępień, Małgorzata Wrzosek, Wioletta Olejarz, Grażyna Kubiak-Tomaszewska, Anna Filipowska, Wojciech Filipowski, Marta Struga

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michał JóźwiakDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. michal.jozwiak@wum.edu.pl.
Karolina StępieńLaboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-097 Warsaw, Poland. karolina.stepien@wum.edu.pl.
Małgorzata WrzosekDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. malgorzata.wrzosek@wum.edu.pl.
Wioletta OlejarzDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. wioletta.olejarz@wum.edu.pl.
Grażyna Kubiak-TomaszewskaDepartment of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. grazyna.kubiak-tomaszewska@wum.edu.pl.
Anna FilipowskaFaculty of Automatic Control, Electronics and Computer Science, Silesian University of Technology, 44-100 Gliwice, Poland. wojciech.filipowski@polsl.pl.
Wojciech FilipowskiDepartment of Biosensors and Processing of Biomedical Signals, Silesian University of Technology, 44-800 Zabrze, Poland. anna.filipowska@polsl.pl.
Marta StrugaLaboratory of Centre for Preclinical Research, Medical University of Warsaw, 02-097 Warsaw, Poland. marta.struga@wum.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thirty new derivatives of palmitic acid were efficiently synthesized. All obtained compounds can be divided into three groups of derivatives: Thiosemicarbazides (compounds

Indexed as

Anti-Infective AgentsCandida albicansGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsPalmitic AcidSemicarbazidesThiadiazolesTriazoles1,2,4-triazole1,3,4-thiadiazoleAnti-Infective AgentsPalmitic AcidSemicarbazidesThiadiazolesthiosemicarbazideTriazoles1,2,4-triazoles1,3,4-thiadiazolesantimicrobial activitypalmitic acid derivativesquantitative structure-activity relationshipthiosemicarbazides

Identifiers

PMID29614061
PMCPMC6017783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.